The HHS Office for Civil Rights (OCR) enforces HIPAA's Privacy, Security, and Breach Notification Rules. OCR has levied settlements or civil money penalties in 152 cases totaling $144.9 million+ since enforcement began. OCR's 2024 Security Risk Analysis Initiative specifically targets organizations that suffered ransomware attacks without having completed a compliant HIPAA risk analysis. Failure to conduct a compliant risk analysis is the #1 cited violation in recent OCR enforcement actions.

Key pharmacy enforcement actions: CVS Pharmacy paid $2.25 million (2009) for improper PHI disposal; Cornell Prescription Pharmacy paid $125,000 (2022) for failure to implement written policies for PHI disposal — the only OCR enforcement action to date specifically involving a small independent pharmacy. Solara Medical Supplies paid $3 million (January 2025) following a ransomware breach; the settlement included a corrective action plan requiring risk analysis revision and compliance reporting to OCR.

The Texas State Board of Pharmacy (TSBP) licenses and regulates all pharmacies and pharmacy professionals operating in Texas. TSBP's Enforcement Division processes complaints and initiates disciplinary actions including license suspension, revocation, administrative penalties, probation, and reprimand. Fines under 22 TAC §281.65 range from $250 to $5,000 per violation.

TSBP's 2025 rulemaking cycle introduced expanded requirements for pharmacies participating in Medicare, Medicaid, and commercial networks. Non-compliance can trigger PBM audit findings and network termination — additive to TSBP disciplinary action. TSBP audit triggers for cybersecurity include: failure to maintain secure pharmacy management system with audit trails; failure to report drug theft/loss to TSBP within required timeframe; controlled substance inventory discrepancies; and pharmacy system breach exposing controlled substance ordering credentials.

DEA's Controlled Substance Ordering System (CSOS) uses PKI technology requiring each DEA registrant to obtain a digital certificate for electronic ordering of Schedule I and II controlled substances. CSOS is the only allowed method for electronic transmission of Schedule II controlled substance orders.

A documented enforcement action: A South Carolina pharmacy's Pharmacist-in-Charge (PIC) failed to properly safeguard his CSOS private login credentials, allowing a staff pharmacist to use the PIC's credentials to place over 100 unauthorized controlled substance orders, resulting in diversion of promethazine with codeine. The pharmacy settled with DEA for $275,000. DEA stated explicitly that the PIC "failed to properly safeguard his [CSOS] private user identification login and password."

DEA civil penalties reach up to $10,000 per violation per day. Criminal referrals to DOJ for knowing diversion violations carry up to 4 years imprisonment. State pharmacy license action (TSBP) is triggered by DEA findings — creating a compounding enforcement cascade from a single incident. DEA Suspicious Order Monitoring (SOM): DEA requires pharmacies to report suspicious orders for controlled substances. A CSOS credential compromise combined with a SOM reporting failure creates a multi-agency exposure unique to pharmacy operations — no other healthcare sector has this parallel criminal liability.

The Texas Data Privacy and Security Act (TDPSA), signed by Governor Greg Abbott on June 18, 2023 and effective July 1, 2024, establishes comprehensive data privacy requirements. HIPAA-covered pharmacies are exempt from TDPSA's core compliance obligations. However, this exemption does not reduce HIPAA obligations — it simply means TDPSA adds no additional cybersecurity burden for most TX independent pharmacies. For TX independent pharmacies that fall outside HIPAA's scope, TDPSA applies with civil penalties up to $7,500 per violation enforced exclusively by the Texas Attorney General.

TMB e-prescribing rules create an additional compliance layer: Texas Medical Board guidance on electronic prescribing of controlled substances requires two-factor authentication for EPCS, with specific requirements for controlled substance handling that intersect with DEA CSOS obligations.

CoreRecon holds Service-Disabled Veteran-Owned Small Business (SDVOSB) certification. Many TX state agencies, hospital systems, and independent pharmacy buying groups have SDVOSB procurement preferences. For a pharmacy that serves any Medicare/Medicaid population or contracts with any Texas state health system, SDVOSB preference status can be the deciding factor in a vendor selection.

CoreRecon requires a Texas-resident Security Operations Center — not a NOC in Mumbai, not a remote agent in the Philippines. For a regulated healthcare entity handling PHI and DEA-controlled substance data, local SOC accountability means: faster incident response (30-minute SLA, contractual and auditable); direct regulatory testimony capability if OCR, TSBP, or DEA investigation requires evidence of security controls in place at the time of incident; and cultural and regulatory familiarity with TSBP rules, Texas pharmacy law, and TX healthcare market dynamics.

CoreRecon's pricing model is specifically calibrated for the independent pharmacy profile — not enterprise organizations that need to justify a six-figure security budget. At $89 per endpoint per month (Sentinel tier) and $129 per endpoint per month (Fortress tier), CoreRecon is cost-competitive with the premium increases that cyber insurance alone has driven in the past 24 months.

Sentinel: $89/endpoint/month — core EDR, 30-min SLA, TX-resident SOC

Fortress: $129/endpoint/month — Sentinel + advanced threat hunting, HIPAA risk monitoring, TSBP audit support

Command: $159/endpoint/month — Fortress + dedicated security architect, quarterly strategic review

All tiers include: 30-minute SLA, TX-resident SOC coverage, SDVOSB procurement documentation, HIPAA security documentation for OCR defense, DEA CSOS credential monitoring, and 24/7 alert response.